[go: up one dir, main page]

PL1709044T3 - Antybiotyki hybrydowe oksazolidynon-chinolon - Google Patents

Antybiotyki hybrydowe oksazolidynon-chinolon

Info

Publication number
PL1709044T3
PL1709044T3 PL04804099T PL04804099T PL1709044T3 PL 1709044 T3 PL1709044 T3 PL 1709044T3 PL 04804099 T PL04804099 T PL 04804099T PL 04804099 T PL04804099 T PL 04804099T PL 1709044 T3 PL1709044 T3 PL 1709044T3
Authority
PL
Poland
Prior art keywords
oxazolidinone
quinolone hybrid
hybrid antibiotics
antibiotics
quinolone
Prior art date
Application number
PL04804099T
Other languages
English (en)
Other versions
PL1709044T5 (pl
Inventor
Christian Hubschwerlen
J L Specklin
Daniel Kaspar Baeschlin
Christine Schmitt
Stefan Müller
Michael Cappi
Original Assignee
Morphochem Aktiengesellschaft Fuer Komb Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39109376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1709044(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP04001506A external-priority patent/EP1557416A1/en
Application filed by Morphochem Aktiengesellschaft Fuer Komb Chemie filed Critical Morphochem Aktiengesellschaft Fuer Komb Chemie
Publication of PL1709044T3 publication Critical patent/PL1709044T3/pl
Publication of PL1709044T5 publication Critical patent/PL1709044T5/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4071Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4071Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4087Esters with arylalkanols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL04804099T 2003-12-18 2004-12-20 Antybiotyki hybrydowe oksazolidynon-chinolon PL1709044T5 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53082203P 2003-12-18 2003-12-18
EP04001506A EP1557416A1 (en) 2004-01-23 2004-01-23 Oxazolidinone-quinolone hybrid antibiotics
EP04804099.2A EP1709044B2 (en) 2003-12-18 2004-12-20 Oxazolidinone-quinolone hybrid antibiotics
PCT/EP2004/014500 WO2005058888A2 (en) 2003-12-18 2004-12-20 Oxazolidinone-quinolone hybrid antibiotics

Publications (2)

Publication Number Publication Date
PL1709044T3 true PL1709044T3 (pl) 2009-01-30
PL1709044T5 PL1709044T5 (pl) 2014-03-31

Family

ID=39109376

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04804099T PL1709044T5 (pl) 2003-12-18 2004-12-20 Antybiotyki hybrydowe oksazolidynon-chinolon

Country Status (21)

Country Link
US (3) US8501774B2 (pl)
EP (1) EP1709044B2 (pl)
JP (2) JP2007516263A (pl)
KR (1) KR101176450B1 (pl)
CN (2) CN1898238A (pl)
AT (1) ATE401326T1 (pl)
AU (1) AU2004299278C9 (pl)
BR (1) BRPI0417193B8 (pl)
CA (1) CA2549675C (pl)
CY (1) CY1108409T1 (pl)
DE (1) DE602004015158D1 (pl)
DK (1) DK1709044T4 (pl)
ES (1) ES2310299T5 (pl)
IL (1) IL175409A (pl)
MX (1) MXPA06006769A (pl)
NZ (1) NZ547382A (pl)
PL (1) PL1709044T5 (pl)
PT (1) PT1709044E (pl)
RU (1) RU2371443C2 (pl)
SI (1) SI1709044T2 (pl)
WO (1) WO2005058888A2 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
EP1620098B1 (en) 2003-04-30 2008-06-11 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
DE10340485B4 (de) * 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
AR054608A1 (es) * 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
US8148362B2 (en) 2006-03-31 2012-04-03 Research Foundation Itsuu Laboratory Compound having heterocyclic ring
US8124623B2 (en) 2006-11-10 2012-02-28 Actelion Pharmaceuticals Ltd. 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials
EP2086968B1 (en) * 2006-11-10 2012-02-08 Actelion Pharmaceuticals Ltd. 5-hydroxymethyl-oxazolidin-2-one derivatives
CL2007003332A1 (es) * 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
WO2009044777A1 (ja) 2007-10-02 2009-04-09 Research Foundation Itsuu Laboratory 7員ヘテロ環を有するオキサゾリジノン誘導体
JP5404652B2 (ja) * 2008-02-22 2014-02-05 アクテリオン ファーマシューティカルズ リミテッド オキサゾリジノン誘導体
CN101965353B (zh) * 2008-03-26 2014-12-17 丹诺医药(苏州)有限公司 共价连接到取代苯基噁唑烷酮的双环硝基咪唑类
CN102239152B (zh) 2008-10-27 2014-10-29 田边三菱制药株式会社 新型酰胺衍生物及其作为药物的用途
EP2776431B1 (en) * 2011-11-08 2016-05-04 Actelion Pharmaceuticals Ltd. 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives
PT3003289T (pt) * 2013-05-28 2019-06-04 Morphochem Gmbh Administração de antibacterianos híbridos de oxazolidinona-quinolona
AU2014273471B2 (en) * 2013-05-28 2019-10-03 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections
CN103435611B (zh) * 2013-09-07 2015-05-27 吉首大学 一类多靶点吡咯酮-喹啉酮型化合物及其制法和用途
CN103483321B (zh) * 2013-09-07 2014-08-13 吉首大学 烷基连接吡咯酮-喹啉酮型化合物及其制法和用途
CN104725330B (zh) * 2013-12-18 2017-06-13 四川好医生药业集团有限公司 噁唑烷酮类化合物及其制备方法和用途
CN107286182A (zh) * 2016-04-12 2017-10-24 李靖 新型噁唑烷酮‑氟喹诺酮衍生物及用途
CN108059624A (zh) * 2016-11-08 2018-05-22 上海医药工业研究院 用于制备咔哒唑胺关键中间体的制备方法
US10087171B2 (en) 2016-12-19 2018-10-02 Actelion Pharmaceuticals Ltd Crystalline forms of cadazolid
CN112898317B (zh) * 2021-01-21 2021-12-07 河南科技大学第一附属医院 一种用于医院护理杀菌消毒的噁唑类化合物及其制备方法和应用
CN114478486B (zh) * 2022-01-28 2023-07-25 西南大学 以对氨基水杨酸为母核的三分子缀合物、中间体、制备方法及用途
TW202415651A (zh) 2022-07-29 2024-04-16 日商住友製藥股份有限公司 含氮飽和雜環衍生物

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840956A (en) 1986-02-18 1989-06-20 Warner-Lambert Company Novel disubstituted-7-pyrrolidinoquinoline antibacterial agents
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH0269478A (ja) 1988-09-05 1990-03-08 Sagami Chem Res Center キノロンカルボン酸誘導体
US5491139A (en) 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
EP0390215B1 (en) 1989-03-30 1995-06-07 Wakunaga Seiyaku Kabushiki Kaisha Quinolone derivatives and salts thereof, preparation process es thereof, and antibacterial agents containing the same
IL100572A (en) 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
CA2119556C (en) 1991-11-01 2004-07-06 Michael Robert Barbachyn Substituted aryl- and heteroaryl-phenyloxazolidinones
US5221676A (en) 1992-02-06 1993-06-22 Warner-Lambert Company 7-substituted quinolones and naphthyridones as antibacterial agents
JP3103380B2 (ja) 1995-09-22 2000-10-30 湧永製薬株式会社 新規ピリドンカルボン酸誘導体又はその塩並びに該物質を有効成分とする抗菌剤
DE19601265A1 (de) 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
DE19633480A1 (de) 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
EP1049682A1 (en) 1998-01-23 2000-11-08 Versicor, Inc. Oxazolidinone combinatorial libraries, compositions and methods of preparation
TW572757B (en) 1998-08-24 2004-01-21 Bristol Myers Squibb Co Novel isoxazolinone antibacterial agents
KR100324621B1 (ko) * 1999-04-27 2002-02-27 박호군 퀴놀론이 치환된 옥사졸리디논 유도체 및 그의 제조 방법과 항균제로서의 용도
EP1200416A1 (en) 1999-07-28 2002-05-02 Pharmacia & Upjohn Company Oxazolidinones and their use as antiinfectives
US6518285B2 (en) 1999-12-21 2003-02-11 Ortho Mcneil Pharmaceutical, Inc. Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
EP1349853B1 (en) * 2000-12-21 2006-03-08 Pharmacia & Upjohn Company LLC Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
ES2186550B2 (es) * 2001-06-27 2003-11-16 Vita Lab Nuevos derivados de oxazolidinonas como antibacterianos.
WO2003031443A1 (en) * 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
WO2003031441A1 (en) * 2001-10-04 2003-04-17 Morphochen Aktiengesellschaft Für Kombinatorische Chemie Multiple action compounds
US6624593B2 (en) 2001-10-08 2003-09-23 Randall D. Blanchard Dimmable ballast for electrodeless fluorescent lamps
US20040132764A1 (en) 2002-10-23 2004-07-08 Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie Antibiotics for the treatment of infections in acidic environments
AU2003202753A1 (en) 2003-02-07 2004-08-30 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
EP1620098B1 (en) * 2003-04-30 2008-06-11 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
DE10340485B4 (de) * 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
AR054608A1 (es) 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
KR200430712Y1 (ko) 2006-08-30 2006-11-13 명 식 신 천장등
EP2086968B1 (en) 2006-11-10 2012-02-08 Actelion Pharmaceuticals Ltd. 5-hydroxymethyl-oxazolidin-2-one derivatives
CL2007003332A1 (es) 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
JP4819980B2 (ja) 2008-05-09 2011-11-24 アクテリオン ファーマシューティカルズ リミテッド 細菌性腸管疾患の治療のための5−ヒドロキシメチル−オキサゾリジン−2−オン誘導体

Also Published As

Publication number Publication date
EP1709044A2 (en) 2006-10-11
MXPA06006769A (es) 2006-12-19
BRPI0417193B8 (pt) 2021-05-25
ATE401326T1 (de) 2008-08-15
US20130296275A1 (en) 2013-11-07
US20120142635A1 (en) 2012-06-07
SI1709044T2 (sl) 2014-02-28
US20150336992A1 (en) 2015-11-26
AU2004299278B2 (en) 2011-03-17
KR101176450B1 (ko) 2012-08-30
WO2005058888A2 (en) 2005-06-30
AU2004299278C9 (en) 2013-10-24
ES2310299T5 (es) 2014-02-10
ES2310299T3 (es) 2009-01-01
BRPI0417193B1 (pt) 2019-01-08
PL1709044T5 (pl) 2014-03-31
CA2549675A1 (en) 2005-06-30
AU2004299278C1 (en) 2013-08-15
SI1709044T1 (sl) 2008-12-31
US9133213B2 (en) 2015-09-15
JP2007516263A (ja) 2007-06-21
JP2012025748A (ja) 2012-02-09
HK1090647A1 (en) 2006-12-29
IL175409A0 (en) 2006-09-05
NZ547382A (en) 2009-11-27
CY1108409T1 (el) 2014-02-12
DE602004015158D1 (de) 2008-08-28
CA2549675C (en) 2012-11-20
AU2004299278A1 (en) 2005-06-30
IL175409A (en) 2011-05-31
US8501774B2 (en) 2013-08-06
EP1709044B1 (en) 2008-07-16
PT1709044E (pt) 2008-10-27
CN1898238A (zh) 2007-01-17
AU2004299278B8 (en) 2011-05-12
KR20070067003A (ko) 2007-06-27
DK1709044T3 (da) 2008-11-03
JP5722149B2 (ja) 2015-05-20
WO2005058888A3 (en) 2005-08-18
RU2006125510A (ru) 2008-01-27
BRPI0417193A (pt) 2007-03-06
CN106957316A (zh) 2017-07-18
DK1709044T4 (da) 2014-01-20
EP1709044B2 (en) 2013-11-20
RU2371443C2 (ru) 2009-10-27

Similar Documents

Publication Publication Date Title
PL1709044T5 (pl) Antybiotyki hybrydowe oksazolidynon-chinolon
PL367517A1 (pl) Antybiotyki o podwójnym działaniu
EG25017A (en) N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials.
GB0127903D0 (en) Improvements relating to organic compounds
CY1108738T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για την αγωγη του πονου
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
IN2012DN00758A (pl)
MXPA04006266A (es) Pirimidotriazinas como inhibidores de fosfatasa.
TW200630367A (en) Substituted adenines and the uses thereof
GB0018951D0 (en) Novel compounds
UA83266C2 (en) Oxazole derivatives of tetracyclines
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
AU2003239581A1 (en) Difluorothioacetamides of oxazolidinones as antibacterial agents
MXPA06000372A (es) Compuestos de silicio y su uso.
GB0027705D0 (en) Novel compounds
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives
BRPI0412360A (pt) compostos de organossilìcio e seu uso
TW200745053A (en) 9-Aminocarbonylsubstituted derivatives of glycylcyclines
TW200514778A (en) Haloalkyl-and piperidine-substituted benzimidazole-derivatives
TW200613301A (en) Novel amino-halogen-imidazopyridines
MX342808B (es) Antibioticos de glicopeptidos.
EP1390056A4 (en) Glycopeptide antibiotics